Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Kaiser Permanente Agency for Healthcare Research and Quality (AHRQ) |
---|---|
Information provided by: | Kaiser Permanente |
ClinicalTrials.gov Identifier: | NCT00211172 |
The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patient's adherence to prescribed beta-blockers following an acute myocardial infarction (heart attack).
Prior to developing patient materials, focus groups were conducted with patient who had previously suffered an AMI to identify the issues and information that patients felt were important to include in our materials as well as the best way to present the information. Additionally, patient materials were “pre-tested” with AMI patients to ensure that the materials were clear and easy to read and that the key messages were understood.
Condition | Intervention |
---|---|
Acute Myocardial Infarction |
Behavioral: Beta-blocker adherence following a myocardial infarction |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | The HMO Research Network CERT: Acute Myocardial Infarction |
Estimated Enrollment: | 980 |
Study Start Date: | October 2003 |
Estimated Study Completion Date: | September 2004 |
Specific Aims:
Research Design and Methods:
We will conduct a randomized controlled trial within the 4 participating HMOs (Kaiser Permanente Northwest, Harvard Pilgrim Health Care, Health Partners, and Kaiser Permanente Georgia). Inpatient data will be used to identify patients with a primary discharge diagnosis of AMI 4-6 months before the extraction date. Practices will be block-randomized to the intervention group or to usual care. To increase repetition of the message, there will be two personalized mailings, occurring at 4-6 months post MI, and at 9 months. The first message will include elements in the table below, and the repeat message will be shorter, but include similar information. The message will come from the patient’s own health plan with the choice of specific individual (e.g. quality assurance department, medical director, or Chief of Cardiology) being informed by our qualitative work. This intervention will be done in collaboration with the cardiovascular care committees and quality assurance departments of participating HMOs.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Clinical diagnosis of Acute Myocardial Infarction (AMI) from 12/1/03 to 5/31/04 and beta-blocker dispensing following AMI and prior to intervention date.
Exclusion Criteria:
None
United States, Georgia | |
Kaiser Permanente-Georgia | |
Atlanta, Georgia, United States, 30305 | |
United States, Massachusetts | |
Harvard Pilgrim Healthcare | |
Boston, Massachusetts, United States, 02115 | |
United States, Minnesota | |
Health Partners | |
Minneapolis, Minnesota, United States, 55440-1309 | |
United States, Oregon | |
Kaiser Permanent Center for Health Research | |
Portland, Oregon, United States, 97227 |
Principal Investigator: | David H Smith, PhD | Kaiser Permanent Center for Health Research |
Study ID Numbers: | 2 U18 HS01391-04 |
Study First Received: | September 13, 2005 |
Last Updated: | April 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00211172 |
Health Authority: | United States: Institutional Review Board |
Acute Myocardial Infarction Heart Attack Adherence Beta-blocker Behavior change |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction |
Pathologic Processes Cardiovascular Diseases |